Broad Autoimmune Screening
Early Immune Detection
Inflammation Assessment
Comprehensive autoimmune and inflammation testing evaluating antibody patterns, immune activation, and systemic inflammation.
Scleroderma & Fibrosis Risk – Anti-Scl-70 and anti-centromere antibodies.
Sjögren’s & Overlap Markers – Anti-SSA (Ro52/Ro60) and anti-SSB for autoimmune gland and connective tissue involvement.
Myositis Marker (Anti-Jo-1) – Associated with inflammatory muscle disease.
Rheumatoid Arthritis Markers – Rheumatoid factor (IgM, IgG) for inflammatory joint disease.
Thyroid Autoimmune Marker (Anti-TPO) – Detects autoimmune thyroid activity.
Complement Levels (C3c, C4c) – Evaluates immune activation and consumption.
Inflammation Markers (hs-CRP, ESR) – Measures systemic inflammatory burden.
Most tests miss early autoimmune activity. This panel evaluates immune dysfunction and inflammation.
Fasting is not required.
Most results return within 7–10 business days.
A positive ANA indicates immune system activity but does not diagnose a specific disease. Results must be interpreted in clinical context.
Yes. Many markers can help track disease activity and systemic inflammation over time.
